1. Al-tuama AM, Abood HAN (2018) A Comparative Study of Salbutamol Nebulizer versus Ipratropium Bromide plus Salbutamol Nebulizer in the Treatment of Children with Acute Asthma A Comparative Study of Salbutamol Nebulizer versus Ipratropium Bromide plus Salbutamol Nebulizer in the Treatment of Children with Acute Asthma Exacerbation. https://www.sciencedirect.com/science/article/abs/pii/0007097186900100
2. Alagusundaram M, Deepthi N, Ramkanth S, Angalaparameswari S, Saleem TSM (2010) Dry powder inhalers—an overview. https://www.researchgate.net/publication/41804469_Dry_Powder_Inhalers_-_An_Overview
3. Amirav I (2004) Aerosol therapy. https://www.researchgate.net/publication/286014367_Aerosol_therapy
4. Berlinski A (2016) Effect of dry powder inhaler resistance on the inspiratory flow rates and volumes of cystic fibrosis patients of six years and older. https://www.researchgate.net/publication/6604894_Nebulized_Drug_Admixtures_Effect_on_Aerosol_Characteristics_and_Albuterol_Output
5. Biddiscombe MF, Melchor R, Mak VHF, Marriot RJ, Taylor AJ (1993) The lung deposition of salbutamol, directly labelled with technetium-99m, delivered by pressurized metered dose and dry powder inhalersa. Int J Pharm 91:111–121. https://doi.org/10.1016/0378-5173(93)90330-I